To clarify the regulatory effects of miR-133b on RCC metastasis progression, we attempted to validate whether miR-133b could regulate the effects of MTA2 on modulating MMP-9 expression and metastasis ability in RCC cells. The gene discussed is MMP9; the disease is renal cell carcinoma.